REGN

REGN EBITDA Margin

37.01%TTM

Period ending:

REGN FY EBITDA Margin%
REGN FY EBITDA Margin129.33%-585.35%
1990-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

REGN ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 36 observations from Dec 31, 1990 to Dec 31, 2025.

Regeneron Pharmaceuticals EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
40.565%
37.4454%
35.7797%
43.2075%
60.1635%
48.2894%
40.71%
40.6792%
38.3006%
29.6631%
32.0257%
30.7071%
38.0569%
36.03%
-38.2501%
-16.4817%
-14.5986%
-25.7153%
-65.6434%
-120.5967%
-102.5728%
39.7869%
-159.1613%
-516.1861%
-362.2901%
-35.1829%
-59.1304%
-24.8691%
-28.0967%
-46.473%
-6.2044%
-107.7586%
-336.7925%
-141.7391%
-120.5479%
-60%

Compare ebitda margin

All REGN financial metrics · REGN stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.